IGM Biosciences, Inc.

NASDAQ:IGMS

16.03 (USD) • At close October 17, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2023202220212020201920182017
Operating Activities:
Net Income -246.416-221.102-165.164-81.355-43.133-22.711-11.054
Depreciation & Amortization 8.2776.0754.4841.0250.5970.2780.161
Deferred Income Tax 0.99200.781-0.023-0.30600
Stock Based Compensation 46.54744.7125.8738.4541.0140.1830.093
Change In Working Capital -6.693155.176.4472.045-5.0242.1790.443
Accounts Receivables 0000.035000
Inventory 000-0.035000
Accounts Payables -0.992-3.0020.6522.1981.961-0.0610.128
Other Working Capital -5.701158.1725.795-0.153-6.9852.240.315
Other Non Cash Items 5.0629.2943.242.5511.7360.0270.287
Operating Cash Flow -192.231-5.853-124.339-67.303-45.116-20.044-10.357
Investing Activities:
Investments In Property Plant And Equipment -12.381-10.206-13.244-17.502-2.337-0.788-0.385
Acquisitions Net 9.4817.368-28.705-57.711200.90100
Purchases Of Investments -365.039-540.022-129.348-208.564-208.90100
Sales Maturities Of Investments 445.775324.584157.41283.777800
Other Investing Activites -9.481-7.36828.70557.711-200.90100
Investing Cash Flow 68.355-225.64414.81857.711-203.238-0.788-0.385
Financing Activities:
Debt Repayment 0000-15-50
Common Stock Issued 115.068217.9874.031216.186265.03217.3378.068
Common Stock Repurchased 00-1.555-1.731-0.32400
Dividends Paid 0000000
Other Financing Activities 1.5041.39500.326282.25822.3378.068
Financing Cash Flow 115.068219.3822.476214.781282.25822.3378.068
Other Information:
Effect Of Forex Changes On Cash 0000000
Net Change In Cash -8.808-12.115-107.045205.18933.9041.505-2.674
Cash At End Of Period 113.112121.92134.035241.0835.8911.9870.482